Study Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Participants With Recurrent Gliomas
Clinical trial NCT01986348 · TERMINATED
Trial details
- NCT number
- NCT01986348
- Sponsor
- Karyopharm Therapeutics Inc
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-03
- Primary completion
- 2020-01-23
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.